Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
14-17 February, 2026
Suppliers Night ExpoSuppliers Night Expo
Not Confirmed
Not Confirmed
16-17 February, 2026
Not Confirmed
Not Confirmed
17-18 February, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
14-17 February, 2026
Suppliers Night ExpoSuppliers Night Expo
Industry Trade Show
Not Confirmed
16-17 February, 2026
Industry Trade Show
Not Confirmed
17-18 February, 2026
Digital content

11 Feb 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260211298909/en/IntraBio-Reports-Further-Detail-on-Positive-Data-from-Levacetylleucine-Pivotal-Trial-for-the-Treatment-of-Ataxia-Telangiectasia

28 Jan 2026
// INDPHARMAPOST
https://www.indianpharmapost.com/news/eu-green-light-to-intrabios-aqneursa-for-rare-neurological-disease-niemann-pick-type-c-18983

22 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260121017823/en/IntraBio-Receives-European-Commission-Approval-of-AQNEURSA-for-the-Treatment-of-Niemann-Pick-Type-C-Disease

22 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260121091020/en/IntraBio-Announces-Positive-Pivotal-Trial-Results-of-Levacetylleucine-for-the-Treatment-of-Ataxia-Telangiectasia

29 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250729653942/en/AQNEURSA-levacetylleucine-Recommended-for-EU-Approval-by-the-CHMP-to-Treat-Niemann-Pick-Disease-Type-C

01 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250701009060/en/IntraBio-Inc.-Completes-Recruitment-for-IB1001-A-T-Pivotal-Clinical-Trial
ABOUT THIS PAGE